Sundrug Co.,Ltd.

TSE:9989.T

4083 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q1
Revenue 194,565185,805194,265189,561182,146170,909180,330172,768166,455157,075164,905162,557164,197153,532164,319159,619156,840153,391147,557164,409152,412143,187152,177147,184145,521138,203147,333140,667138,012129,019138,672131,034129,669124,780131,806125,531121,656113,043120,703111,302100,770116,773113,659109,373108,014100,226107,392101,99097,79394,587101,98197,02993,23989,37994,19390,81986,26493,35264,79364,18061,786
Cost of Revenue 145,408139,043144,657141,831136,926126,631134,859130,583126,443119,198124,636123,457124,937115,289122,761119,926117,784114,919110,221123,948114,062106,743114,071110,620109,457102,787110,587105,880104,00296,090104,48098,96098,11693,38699,58094,44492,24484,67691,30785,22176,37889,16987,11682,92382,76675,78182,54977,63474,90671,51678,75974,65772,01568,52873,14870,15667,02573,38548,90748,61247,408
Gross Profit 49,15746,76249,60847,73045,22044,27845,47142,18540,01237,87740,26939,10039,26038,24341,55839,69339,05638,47237,33640,46138,35036,44438,10636,56436,06435,41636,74634,78734,01032,92934,19232,07431,55331,39432,22631,08729,41228,36729,39626,08124,39227,60426,54326,45025,24824,44524,84324,35622,88723,07123,22222,37221,22420,85121,04520,66319,23919,96715,88615,56814,378
Gross Profit Ratio 0.2530.2520.2550.2520.2480.2590.2520.2440.240.2410.2440.2410.2390.2490.2530.2490.2490.2510.2530.2460.2520.2550.250.2480.2480.2560.2490.2470.2460.2550.2470.2450.2430.2520.2440.2480.2420.2510.2440.2340.2420.2360.2340.2420.2340.2440.2310.2390.2340.2440.2280.2310.2280.2330.2230.2280.2230.2140.2450.2430.233
Reseach & Development Expenses 0000000000000000000000000000000000000000000000000000000000000
General & Administrative Expenses 05.500000000000000000000000000000000000000000000000000000000000
Selling & Marketing Expenses 038,976.500000000000000000000000000000000000000000000000000000000000
SG&A 38,23638,98237,00137,02135,31936,31934,48932,73130,95431,26730,75630,77129,66030,90431,22330,72128,35629,61829,37430,20428,80027,89228,34528,24627,18826,61926,70626,13725,15824,60024,68723,98023,24023,44123,07822,69721,65121,26121,37620,42619,10519,96319,44219,27118,82418,01018,28117,9030000000000000
Other Expenses 0152189116178228156125851121691251248120526311179135100112891187615316116214811118517915815619419716496133151105642191421021371341371355899123100134140141151881341597653
Operating Expenses 38,23638,98237,00137,02135,31936,31734,48932,73130,95431,26730,75630,77129,66030,90131,22330,72128,35629,63329,37430,20428,80028,16228,34528,24627,18826,87426,70626,13725,15824,78324,68723,98023,24023,66523,07822,69721,65121,40221,37620,42619,10520,24819,44219,27118,82418,23518,28117,90317,388-10,64717,58816,83116,080-9,37415,84515,80915,066-4,55612,08611,07910,676
Operating Income 10,9217,78012,60710,7109,8997,95910,9829,4539,0586,6119,5138,3299,5997,33910,3358,97110,7008,8367,96110,2579,5508,2799,7618,3188,8758,53910,0408,6508,8518,1449,5068,0938,3127,7279,1478,3907,7616,9638,0205,6545,2877,3547,1017,1806,4226,2086,5626,4525,4985,9465,6345,5395,1445,0075,1994,8534,1714,0293,7994,4893,701
Operating Income Ratio 0.0560.0420.0650.0560.0540.0470.0610.0550.0540.0420.0580.0510.0580.0480.0630.0560.0680.0580.0540.0620.0630.0580.0640.0570.0610.0620.0680.0610.0640.0630.0690.0620.0640.0620.0690.0670.0640.0620.0660.0510.0520.0630.0620.0660.0590.0620.0610.0630.0560.0630.0550.0570.0550.0560.0550.0530.0480.0430.0590.070.06
Total Other Income Expenses Net -342152128-18016382174-9596137104-8391-230177377-485-2,23214426103-28119-69165153160174277312410267-2127130-531316811448-1,135166315788119126-29-27,77413660-3-25,17315022-586-20,4691326364
Income Before Tax 10,5797,93212,73510,53010,0648,04111,1569,3589,1556,7479,6188,3209,9907,11210,5129,34910,2156,6078,10510,2839,6538,0029,7808,2499,0408,69610,1998,8248,8798,2199,6308,1958,3807,7279,2748,5207,7567,2778,1885,7695,3356,2217,2667,2116,4806,2996,6806,5795,4705,9445,7705,6015,1415,0525,3504,8763,5874,0543,9324,5523,766
Income Before Tax Ratio 0.0540.0430.0660.0560.0550.0470.0620.0540.0550.0430.0580.0510.0610.0460.0640.0590.0650.0430.0550.0630.0630.0560.0640.0560.0620.0630.0690.0630.0640.0640.0690.0630.0650.0620.070.0680.0640.0640.0680.0520.0530.0530.0640.0660.060.0630.0620.0650.0560.0630.0570.0580.0550.0570.0570.0540.0420.0430.0610.0710.061
Income Tax Expense 3,2891,5874,0083,3753,1642,7033,5132,9352,8561,8983,0682,6673,1882,5093,2642,9223,1641,9092,6443,2933,1102,4313,1412,6602,9052,7713,2922,8412,8642,5333,1602,6832,7362,6703,2703,0182,7502,9083,0952,1802,0243,0912,9062,8462,5812,5872,6552,6332,1972,4952,7662,4082,2061,9072,3042,1041,6811,7561,6471,8901,571
Net Income 7,2906,3458,7277,1546,9005,3397,6426,4246,2984,8496,5495,6546,8014,6047,2476,4277,0514,6985,4626,9896,5435,5706,6405,5896,1345,9256,9065,9836,0155,6866,4715,5125,6435,0586,0035,5035,0054,3705,0933,5883,3113,1304,3604,3663,8983,7114,0263,9463,2723,4493,0033,1942,9343,1463,0462,7721,9062,2992,2842,6622,194
Net Income Ratio 0.0370.0340.0450.0380.0380.0310.0420.0370.0380.0310.040.0350.0410.030.0440.040.0450.0310.0370.0430.0430.0390.0440.0380.0420.0430.0470.0430.0440.0440.0470.0420.0440.0410.0460.0440.0410.0390.0420.0320.0330.0270.0380.040.0360.0370.0370.0390.0330.0360.0290.0330.0310.0350.0320.0310.0220.0250.0350.0410.036
EPS 62.3354.2574.6261.1859.0145.6665.3654.9453.8641.4756.0148.3658.1839.3861.9954.9860.3240.1946.7259.7955.9847.6556.847.8252.4850.6959.0851.0751.3548.5455.2445.646.6941.8449.6645.5241.4136.1542.1328.4726.2724.8334.5934.6430.9329.4431.9431.3125.9627.3623.8225.3423.2824.9624.1721.9915.1318.2418.1221.1217.41
EPS Diluted 62.3354.2574.6261.1859.0145.6665.3554.9453.8641.4756.0148.3558.1839.3861.9954.9860.340.1946.7259.7955.9847.6556.847.8252.4850.6959.0851.0751.3448.5455.2445.646.6841.8449.6645.5241.4136.1542.1328.4726.2724.8334.5934.6430.9329.4431.9431.3125.9627.3623.8225.3423.2824.9624.1721.9915.1318.2418.1221.1217.41
EBITDA 14,89412,13412,83210,85710,1098,21411,1739,6149,1706,7519,7178,4849,7567,45310,5769,26610,8438,9478,13110,3929,6978,4009,9178,4269,0638,73110,2388,8338,9978,3709,7198,2868,5037,9609,3818,5917,8917,1308,2055,7905,3847,6097,2747,3146,5916,3736,7336,6155,58333,8455,7825,6655,30231,5576,4456,0285,22825,8584,7475,2294,349
EBITDA Ratio 0.0770.0650.0660.0570.0550.0480.0620.0560.0550.0430.0590.0520.0590.0490.0640.0580.0690.0580.0550.0630.0640.0590.0650.0570.0620.0630.0690.0630.0650.0650.070.0630.0660.0640.0710.0680.0650.0630.0680.0520.0530.0650.0640.0670.0610.0640.0630.0650.0570.3580.0570.0580.0570.3530.0680.0660.0610.2770.0730.0810.07